Hematology Analyzer And Reagent Market

Hematology Analyzer and Reagent market is valued at USD 3654.18 million in 2018 and expected to reach USD 6344.23 million by 2025 with a CAGR of 8.20% over the forecast period.

Market Analysis of Hematology Analyzer and Reagent Market –

Hematology is a branch of medicine concerned with the learning, diagnosis, treatment, and anticipation of diseases related to the blood. Hematology analyzers and reagents are used in the diagnosis treatment of a broad range of diseases associated to red blood cell, white blood cell, platelets, bone marrow and the protein involve in bleeding and clotting. It also regulates plasma drug level for both therapeutic and illicit drug.

Global Hematology Analyzer and Reagent Market report is segmented on the basis of product, applications, end users and by regional & country level. Based upon product, global hematology analyzer and reagent market is segmented into hematology analyzers, hemostasis analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzer, coagulation analyzer, flow cytometers, slide stainers, differential counters and hematology stains. Based on applications the hematology analyzer and reagent market is segmented in to anemia, blood cancer, hemorrhagic conditions, infection-related conditions, immune system related conditions and others. Based upon end users global hematology analyzer and reagent market is segmented into hospitals, commercial service providers, reference laboratories, and research & academic institutes.

The regions covered in this Hematology Analyzer and Reagent Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Hematology Analyzer and Reagent is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players -

Some major key players for global Hematology Analyzer and Reagent market are

• Abbott Laboratories
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Boule Diagnostics
• Diatron
• Drew Scientific
• EKF Diagnostics
• Horiba, Ltd.
• Mindray
• Nihon Kohden Corporation
• Ortho Clinical Diagnostics
• Roche Diagnostics
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• Sysmex Corporation
• Others

Market Dynamics –

Rising numbers of blood disorders and increase in blood donation are the major factors driving the growth of the global hematology products market. However, high initial setup cost and a stringent regulatory environment are some factors restraining the growth of the market. For instance, Abbott Diagnostics launches CELL-DYN Ruby* hematology analyzer whose costs around USD 185,000 which is high. Moreover, factors such as technological advancements in hematology analyzers and reagents and combination of flow cytometry techniques with hematology analyzers and merger & acquisition are likely to support growth opportunity for the market. For instance, in 2012, Transasia acquired IAS Diagnostics and Bio-Rad introduced Liquichek Hematology and Reticulocyte Controls.

The global hematology analyzer and reagent market is segmented into North America, Europe, Asia-Pacific and Rest of the World (ROW). North America is the leading contributor to the market due to increasing prevalence of cancer and anemia, development in healthcare facilities and increase in number of highly advanced diagnostic clinics are some of the factor propelling the growth of the market in this region. According to American Cancer Society, Non Hodgkin lymphoma is one of the more common types of cancer in United States, accounting for 4% of all cancer. As estimated 74,680 diagnoses will take place in the U.S. in 2018. 70% of people diagnosed with Non-Hodgkin’s lymphoma live at least 5 years after being diagnosed. These kinds of hematological disorder propel the growth of the market. Asia-Pacific region is expected to witness profitable growth in the forecast period due to presence of untapped opportunities especially in the developing economies like India and China.

Key Benefits for Market Reports–

• Global Hematology Analyzer and Reagent Market report covers in-depth historical and forecast analysis.
• Global Hematology Analyzer and Reagent Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Hematology Analyzer and Reagent Market report helps to identify opportunities in marketplace.
• Global Hematology Analyzer and Reagent Market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation -

By Product Type

• Hematology Analyzers
• Hematology Reagents

By Application

• Anemia
• Leukemia
• Lymphoma
• Other

By End-User

• Hospitals
• Clinical Laboratories
• Research Institutes

Regional & Country Analysis

• North America

• US.
• Canada

• Europe

• UK.
• France
• Germany
• Italy

• Asia Pacific

• China
• Japan
• India
• Southeast Asia

• Latin America

• Brazil
• Mexico

• Middle East and Africa

• GCC
• Africa
• Rest of Middle East and Africa